| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 740385 | 7-fluoro-2-benzoyl-3-trifluoromethylquioxaline 1,4-dioxide | 0.0141370771633662 | 0.23451928 |
| NSC 744025 | diethyl 2-[4-(5-[(11aS)-7-methoxy-5-oxo-2,3,5,11a-tetrahydro-1H-benzo[e]pyrrolo[1,2-a][1,4]diazepin-8-yl]oxypentyl)piperazino]ethylphosphonate | 0.0141370771633662 | 0.23104338 |
| NSC 747452 | 3,19-(4-Acetamido)benzylidineandrographolide | 0.0141370771633662 | 0.44993048 |
| NSC 749379 | Null | 0.0141370771633662 | 0.38235713 |
| NSC 763646 | (E)-2-(2-(benzo[d][1,3]dioxol-5-yl)vinyl)-5-(3-methyl-1H-pyrazol-5-yl)-1,3,4-oxadiazole | 0.0141370771633662 | 0.32422692 |
| NSC 99733 | Rheumygin | 0.0141370771633662 | 0.19549051 |
| NSC 140380 | Ethanesulfonic acid, compd. with 4-[[2-chloro-4-(4,6-diamino-2,2-dimethyl-1,3,5-triazin-1(2H)-yl)phenoxy]acetyl]morpholine (1:1) (9CI) (MF2) | 0.0144962130699212 | 0.23515074 |
| NSC 160121 | 1H,5H-Benzo[ij]quinolizine, 2,3,6,7-tetrahydro-9-(octylamino)-, dihydrochloride | 0.0144962130699212 | 0.39173185 |
| NSC 265211 | NSC 265211 | 0.0144962130699212 | 0.30676856 |
| NSC 335989 | Acetamide, 2,2,2-trifluoro-N-(5,6,7,9-tetrahydro-2-hydroxy-1,3,10-trimethoxy-9-oxobenzo[a]heptalen-7-yl)-, (S)- | 0.0144962130699212 | 0.11763963 |